|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.490 CAD | +0.68% |
|
-1.32% | -35.50% |
| 05-12 | Organigram Global Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2026 | CI |
| 05-12 | Organigram Global Inc. Updates Revenue Guidance for the Fiscal Year 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Medical Farming
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 150M | - | - | |||
| 118M | - | - | |||
| 112M | - | ||||
| 98.89M | - | ||||
| 47.47M | - | - | - | - | - |
- Stock Market
- Stocks
- OGI Stock
- Charts Organigram Global Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
